Memory Problems Linked to Slower Rate of Decline in Alzheimer’s

June is Alzheimer’s and Brain Awareness Month. Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia.

Translate to Spanish or other 102 languages!

Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia. Image for illustration purposes
Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia. Image for illustration purposes

Mega Doctor News

- Advertisement -

CLEVELAND CLINIC – June is Alzheimer’s and Brain Awareness Month.

Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia.

“What we found out was that people with early memory symptoms alone compared to people with early language problems or visual-spatial problems, they tend to have a slightly slower disease progression in terms of their functional abilities,” explained Jagan Pillai, MD, neurologist for Cleveland Clinic and lead author on the study.

- Advertisement -

Dr. Pillai said those with language problems, spatial ability and judgment issues seemed to be affected more over a period of time – specifically in their daily functional abilities.

He said it seems to make sense since a person with just memory difficulties could find other ways to compensate, like keeping track of what they’re doing by recording themselves or writing down notes. That would then allow them to remain functional.

He also noted that memory difficulties come from another part of the brain than language problems, for example. So, how the disease progresses could be different.

“The portion of the brain that is first impacted by the disease tends to determine the symptoms that goes along with the disease and also the kind of progression from there to other regions,” said Dr. Pillai.

- Advertisement -

Dr. Pillai said having this information available can better help physicians diagnose people and prepare them for the future.

It can also be useful for researchers when it comes to testing different medications to treat Alzheimer’s disease.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

STHS GME Consortium Encourages Community to “Walk with a Doc”, June 6th

Mega Doctor News In an era defined by high-intensity workouts, wearable fitness trackers and advanced training techniques, one of simplest...

Study: Menopause Hormone Therapy Declines Nationwide Despite Proven Benefits

Hormone therapy use among women in the U.S. remains low, even though it's an effective treatment for many menopause symptoms, according to a new Mayo Clinic study published in Mayo Clinic Proceedings.
- Advertisement -